UK Drug Co. Settles For $19.6M Over False Safety Claims
A New York federal judge has granted final approval to a $19.6 million settlement between investors and U.K.-based consumer goods and health conglomerate Reckitt Benckiser Group PLC, resolving claims that it...To view the full article, register now.
Already a subscriber? Click here to view full article